Cargando…
Fucosylated N-glycans as early biomarkers of COVID-19 severity
BACKGROUND: The pathological mechanisms of SARS-CoV-2 in humans remain unclear and the unpredictability of COVID-19 progression may be attributed to the absence of biomarkers that contribute to the prognosis of this disease. Therefore, the discovery of biomarkers is needed for reliable risk stratifi...
Autores principales: | Paton, Beatrix, Herrero, Pol, Peraire, Joaquim, del Pino, Antoni, Chafino, Silvia, Martinez-Picado, Javier, Gómez-Bertomeu, Fréderic, Rull, Anna, Canela, Núria, Suárez, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278543/ https://www.ncbi.nlm.nih.gov/pubmed/37342334 http://dx.doi.org/10.3389/fimmu.2023.1204661 |
Ejemplares similares
-
Glycosylation Biomarkers Associated with Age-Related Diseases and Current Methods for Glycan Analysis
por: Paton, Beatrix, et al.
Publicado: (2021) -
Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV
por: Espineira, Sonia, et al.
Publicado: (2023) -
Brain N-Glycosylation and Lipidomic Profile Changes Induced by a High-Fat Diet in Dyslipidemic Hamsters
por: Paton, Beatrix, et al.
Publicado: (2023) -
Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery
por: Sánchez, Alba, et al.
Publicado: (2023) -
Metabolic Labeling of Fucosylated Glycans in Developing Zebrafish
por: Dehnert, Karen W., et al.
Publicado: (2011)